These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 26569423)

  • 1. MicroRNA networks in pulmonary arterial hypertension: share mechanisms with cancer?
    Courboulin A; Ranchoux B; Cohen-Kaminsky S; Perros F; Bonnet S
    Curr Opin Oncol; 2016 Jan; 28(1):72-82. PubMed ID: 26569423
    [TBL] [Abstract][Full Text] [Related]  

  • 2. microRNA and Pulmonary Hypertension.
    Boucherat O; Potus F; Bonnet S
    Adv Exp Med Biol; 2015; 888():237-52. PubMed ID: 26663186
    [TBL] [Abstract][Full Text] [Related]  

  • 3. miRNAs in PAH: biomarker, therapeutic target or both?
    Meloche J; Pflieger A; Vaillancourt M; Graydon C; Provencher S; Bonnet S
    Drug Discov Today; 2014 Aug; 19(8):1264-9. PubMed ID: 24881781
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reversal of MicroRNA Dysregulation in an Animal Model of Pulmonary Hypertension.
    Gubrij IB; Pangle AK; Pang L; Johnson LG
    PLoS One; 2016; 11(1):e0147827. PubMed ID: 26815432
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNAs: promising therapeutic targets for the treatment of pulmonary arterial hypertension.
    Yuan K; Orcholski M; Tian X; Liao X; de Jesus Perez VA
    Expert Opin Ther Targets; 2013 May; 17(5):557-64. PubMed ID: 23379818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA and lncRNA as the Future of Pulmonary Arterial Hypertension Treatment.
    Wołowiec Ł; Mędlewska M; Osiak J; Wołowiec A; Grześk E; Jaśniak A; Grześk G
    Int J Mol Sci; 2023 Jun; 24(11):. PubMed ID: 37298685
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pulmonary arterial hypertension and microRNAs--an ever-growing partnership.
    Wang Y; Xue XY; Liu YX; Wang KF; Zang XF; Wang J; Wang PL; Zhang J; Pan L; Zhang SY; Wang JX
    Arch Med Res; 2013 Oct; 44(7):483-7. PubMed ID: 24051036
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-145-targeted drug and its preventive effect on pulmonary arterial hypertension (patent WO2012153135 A1).
    Ogorodnikova N; Arenz C
    Expert Opin Ther Pat; 2015 Jun; 25(6):723-7. PubMed ID: 25787302
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA in pulmonary vascular disease.
    Rothman AM; Chico TJ; Lawrie A
    Prog Mol Biol Transl Sci; 2014; 124():43-63. PubMed ID: 24751426
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic implications of microRNAs in pulmonary arterial hypertension.
    Lee A; McLean D; Choi J; Kang H; Chang W; Kim J
    BMB Rep; 2014 Jun; 47(6):311-7. PubMed ID: 24755557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent progress in the roles of microRNAs in pulmonary arterial hypertension associated with congenital heart disease.
    Siregar FM; Hartopo AB; Haryana SM
    Narra J; 2024 Apr; 4(1):e579. PubMed ID: 38798867
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNAs and their regulators: Potential therapeutic targets in pulmonary arterial hypertension.
    He YZ; Wang YX; Ma JS; Li RN; Wang J; Lian TY; Zhou YP; Yang HP; Sun K; Jing ZC
    Vascul Pharmacol; 2023 Dec; 153():107216. PubMed ID: 37699495
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNAs in pulmonary arterial hypertension: pathogenesis, diagnosis and treatment.
    Bienertova-Vasku J; Novak J; Vasku A
    J Am Soc Hypertens; 2015 Mar; 9(3):221-34. PubMed ID: 25660363
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA Damage and Pulmonary Hypertension.
    Ranchoux B; Meloche J; Paulin R; Boucherat O; Provencher S; Bonnet S
    Int J Mol Sci; 2016 Jun; 17(6):. PubMed ID: 27338373
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular Mechanisms of Pulmonary Vascular Remodeling in Pulmonary Arterial Hypertension.
    Leopold JA; Maron BA
    Int J Mol Sci; 2016 May; 17(5):. PubMed ID: 27213345
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent research progress of microRNAs in hypertension pathogenesis, with a focus on the roles of miRNAs in pulmonary arterial hypertension.
    Miao C; Chang J; Zhang G
    Mol Biol Rep; 2018 Dec; 45(6):2883-2896. PubMed ID: 30298350
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Downregulation of MicroRNA-126 Contributes to the Failing Right Ventricle in Pulmonary Arterial Hypertension.
    Potus F; Ruffenach G; Dahou A; Thebault C; Breuils-Bonnet S; Tremblay È; Nadeau V; Paradis R; Graydon C; Wong R; Johnson I; Paulin R; Lajoie AC; Perron J; Charbonneau E; Joubert P; Pibarot P; Michelakis ED; Provencher S; Bonnet S
    Circulation; 2015 Sep; 132(10):932-43. PubMed ID: 26162916
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Female gender and pulmonary arterial hypertension: a complex relationship].
    Manes A; Palazzini M; Dardi F; D'Adamo A; Rinaldi A; Galiè N
    G Ital Cardiol (Rome); 2012 Jun; 13(6):448-60. PubMed ID: 22622125
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The etiopathogenesis of pulmonary hypertension: inflammation, vascular remodeling].
    Kayikçioğlu M
    Anadolu Kardiyol Derg; 2010 Aug; 10 Suppl 1():5-8. PubMed ID: 20819761
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The emerging role of microRNAs in hypoxia-induced pulmonary hypertension.
    Mohsenin V
    Sleep Breath; 2016 Sep; 20(3):1059-67. PubMed ID: 27154628
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.